-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
Beijing Nuokangda
Beijing Nuokangda Pharmaceutical Technology Co., Ltd. is a full-chain pharmaceutical CRO enterprise with an innovative formulation technology platform oriented towards clinical needs. It is a national high-tech enterprise, a national intellectual property demonstration enterprise, and a postdoctoral workstation; for six consecutive years, it has been ranked among the top 20 pharmaceutical R&D companies in China by the All-China Federation of Industry and Commerce, and has undertaken and participated in two major national new drug creation projects during the 13th Five-Year Plan period.
In 2023, Keyuan Pharmaceutical reached a strategic equity cooperation with Beijing Nuokangda, becoming Nuokangda's second-largest shareholder. Nuokangda has now become Keyuan Pharmaceutical's Beijing R&D base.
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline